Back
NioCorp Developments Vs. Edgewise Therapeutics Industry Stock Comparison
Sell
19
NB
NioCorp Developments
Last Price:
1.75
Seasonality Move:
4.49%
Buy
72
EWTX
Edgewise Therapeutics
Last Price:
30.01
Seasonality Move:
13.73%
Sell
19
NioCorp Developments (NB)
is a Sell
Is NioCorp Developments a Buy, Sell or Hold?
- The current NioCorp Developments [NB] share price is $1.72. The Score for NB is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- NB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
72
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy, Sell or Hold?
- The current Edgewise Therapeutics [EWTX] share price is $30.33. The Score for EWTX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- EWTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NB Stock Price Chart
What is NioCorp Developments's stock price today?
-
The NioCorp Developments share price today is $1.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NB is experiencing slight buying pressure.
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $30.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
NB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 43.71 | Sell |
Chaikin Money Flow: | 37407 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.67 - 1.93) | Sell |
Bollinger Bands (100): | (1.7 - 2.1) | Sell |
EWTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.47 | Buy |
Relative Strength Index (14 RSI): | 71.49 | Buy |
Chaikin Money Flow: | 1376532 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.65 - 28.39) | Buy |
Bollinger Bands (100): | (16.13 - 23.39) | Buy |
NB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.84 | Sell |
20-day SMA: | 1.81 | Sell |
50-day SMA: | 1.83 | Sell |
200-day SMA: | 2.32 | Sell |
8-day EMA: | 1.79 | Sell |
20-day EMA: | 1.82 | Sell |
50-day EMA: | 1.85 | Sell |
200-day EMA: | 2.45 | Sell |
EWTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.85 | Buy |
20-day SMA: | 25.06 | Buy |
50-day SMA: | 20.75 | Buy |
200-day SMA: | 17.95 | Buy |
8-day EMA: | 27.95 | Buy |
20-day EMA: | 25.53 | Buy |
50-day EMA: | 22.44 | Buy |
200-day EMA: | 17.77 | Buy |
NioCorp Developments Earnings Growth & NB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $0.09 per share.
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.35 per share.
NioCorp Developments Technical Analysis
Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Edgewise Therapeutics Technical Analysis
Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |